Chemotherapeutic activity of liposomal SJA-95: A new polyene macrolide antibiotic in experimental aspergillosis and cryptococcosis

Biomedicine and Pharmacotherapy

Volumn 63, Issue 4, 2009, Pages 287-292

  Desai, Sandhya K ^a   Naik, Suresh R ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Antifungal; Aspergillosis; Cryptococcosis; Liposomes

Indexed keywords

LIPOSOMAL SJA 95; LIPOSOME; MACROLIDE; POLYENE ANTIBIOTIC AGENT; PRO LIPO 3080 S; SJA 95; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG FORMULATION; LD 50; LEUKOCYTE DIFFERENTIAL COUNT; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EVALUATION, PRECLINICAL; FUNGEMIA; KIDNEY; LETHAL DOSE 50; LEUKOCYTE COUNT; LIPOSOMES; LIVER; LUNG; MACROLIDES; MICE; POLYENES; SPLEEN;

EID: 64749092290     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.08.017     Document Type: Article

References (19)

1. Hoban D.J., Zhanel G.G., and Karlowsky J.A. In vitro susceptibility of Candida and Cryptococcus neoformans from blood cultures and neutropenic patients. Antimicrob Agents Chemother 43 6 (1999) 1463-1464
2. Nicolle L.E., Rotstein C., Bourgault A.M., St-Germain G., and Garber G. The Canadian Infections Invasive Fungal Registry. Invasive fungal infections in Canada from 1992 to 1994. Can J Infect Dis 9 (1998) 347-352
3. Trullas J.C., Cervera C., Benito N., Puig J., Agusti C., Rovira M., et al. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc 37 (2005) 4091-4093
4. Runyoro D., Matee M., Ngassapa O., Joseph C., and Mbwambo Z. Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Complem Altern Med 6 (2006) 11
5. Therese K.L., Bagyalakshmi R., Madhavan H.N., and Deepa P. In vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of Amphotericin B, Fluconazole and Ketoconazole against ocular fungal isolates. Indian J Microbiol 24 4 (2006) 273-279
6. Dietrich M.A. New advances in fungal pharmacotherapy: Voriconazole and Caspofungin. Inet Ce 221-146-04-069-H01 (2004)
7. Naik S.R., Desai S.K., Nanda R.K., and Narayanan M.S. Fermentation, isolation, purification and biological activity of SJA-95, a heptaene polyene macrolide antibiotic produced by Streptomyces sp. strain S-24. Arzneim Forsch (Drug Res) 57 3 (2007) 171-179
8. Desai S.K., and Naik S.R. Probable mechanism of antifungal activity of SJA-95, a heptaene polyene antibiotic. Indian J Pharm Sci 70 (2008) 165-169
9. Allen T.M. Liposomes: opportunities in drug delivery. Drugs 54 (1997) 8-14
10. Rapp R.P., Gubbuns P.O., and Evans M.E. Amphotericin-B lipid complex. Ann Pharmacother 31 (1997) 1174-1186
11. Harindran J., Chakraborty K.K., and Naik S.R. Preparation, relative toxicity and therapeutic efficacy in mice and rats of liposomal HA-1-92, a new oxohexaene polyene macrolide antibiotic. J Pharm Pharmacol 51 (1999) 771-776
12. Chakraborty K.K., and Naik S.R. Pharmacokinetic studies of in-situ liposomal preparation containing Amphotericin B complex with different chemically modified β-cyclodextrins. J Lipids Res 11 1 (2001) 1-14
13. Perrett S., Golding M., and Williams P. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol 43 (1991) 154-161
14. Litchfield J.T., and Wilcoxon F.W. A simplified method of evaluating dose effect experiments. J Pharmacol Exp Ther 96 (1949) 99-113
15. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., and Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42 4 (1982) 1412-1422
16. Schaffner A., Douglas H., and Braude A. Selective protection against Conidia by mononuclear and against Mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 69 (1982) 617-631
17. Wanner A., Salathe M., and O'Riordan T.G. Mucociliary clearance in the airways. Am J Respir Crit Care Med 154 (1996) 1868-1902
18. Romani L., and Kaufmann S.H.E. Editorial overview: Immunity to fungi. Res Immunol 149 (1998) 277-524
19. Takemoto K., Yamamoto Y., Ueda Y., Sumita Y., Yoshida K., and Niki Y. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis. J Antimicrob Chem Ther 57 4 (2006) 724-731